• Clover Health's stock is up 4.35% to $5.28, extending a recent positive trend.
  • This rebound is largely attributed to the company's Medicare Advantage plans receiving upgraded 4.5-Star CMS ratings for 2027, following a court-ordered recalculation earlier this month.
  • The improved ratings are expected to positively impact the company's payments and bonus eligibility for the upcoming year.